A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/2011
12/08/2011	US20110301180 Reducing Platelet Activation, Aggregation and Platelet-Stimulated Thrombosis or Blood Coagulation by Reducing Mitochondrial Respiration
12/08/2011	US20110301168 Cycloalkane[b]azaindole antagonists of prostaglandin d2 receptors
12/08/2011	US20110301166 Method for the prevention of thromboembolic disorders
12/08/2011	US20110301163 Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and sirt1, and methods of treating disorders
12/08/2011	US20110301159 Kinase inhibitor compounds
12/08/2011	US20110301148 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
12/08/2011	US20110301144 Kinase Antagonists
12/08/2011	US20110301143 Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/08/2011	US20110301136 Nitrate Esters Of Corticoid Compounds Useful As Diuretics
12/08/2011	US20110301134 Alkyne antagonists of lysophosphatidic acid receptors
12/08/2011	US20110301122 Heteroaromatic compounds for use as hif inhibitors
12/08/2011	US20110301120 Use of a chitosan polymer for heparin neutralization
12/08/2011	US20110301112 Fused ring thrombin receptor antagonists
12/08/2011	US20110301102 Compositions and methods for treating myelodysplastic syndrome
12/08/2011	US20110301097 Oral Administration Of Therapeutic Agent Coupled To Transporting Agent
12/08/2011	US20110301096 Prodrug of an ice inhibitor
12/08/2011	US20110301095 Methods and compositions for assessing and treating metastasis, metastatic cancer, and potential for metastasis
12/08/2011	US20110301088 Crystalline ezatiostat hydrochloride ansolvate
12/08/2011	US20110301077 Method for production of lactoferrin
12/08/2011	US20110300242 Novel botanical formulation for treating sickle cell disease
12/08/2011	US20110300239 Blood flow improving agent
12/08/2011	US20110300237 Protective solutions for organs
12/08/2011	US20110300221 Therapeutic Inhibitor of Vascular Smooth Muscle Cells
12/08/2011	US20110300193 Ambient stored blood plasma expanders
12/08/2011	US20110300160 Sulfation of wnt pathway proteins
12/08/2011	US20110300158 Anti-serum albumin binding variants
12/08/2011	US20110300142 Use of zeburaline for the treatment of autoimmune diseases or immune rejection of transplants
12/08/2011	US20110300136 Therapy of autoimmune disease in a patient with an inadequate response to a tnf-alpha inhibitor
12/08/2011	US20110300128 Use of foxp2 as a marker for abnormal lymphocytes and as a target for therapy of disorders associated with abnormal lymphocytes
12/08/2011	US20110300122 Method for treating a patient
12/08/2011	US20110300071 Targeting npr-c in angiogenesis and atherosclerosis with a c-type atrial natriuretic factor (canf)-comb nanocomplex
12/08/2011	CA2801226A1 Processes for the preparation of dipyridamole
12/08/2011	CA2801120A1 Process for making dry and stable hemostatic compositions
12/08/2011	CA2801118A1 Process for making dry and stable hemostatic compositions
12/08/2011	CA2801030A1 Crystal of thienopyrimidine derivative
12/08/2011	CA2800523A1 Purinone derivative
12/07/2011	EP2392594A1 N-terminally monopegylated polypeptides and process for their preparation
12/07/2011	EP2391367A1 Nampt and vitamin b3 for treating or preventing diseases
12/07/2011	EP2391352A1 Pharmaceutical forms for the release of active compounds
12/07/2011	EP2391341A2 Resuscitation fluid
12/07/2011	CN1494425B 用作治疗剂的羧酰胺衍生物 As therapeutic agents carboxamide derivatives
12/07/2011	CN102272160A 抗rhd单克隆抗体 Monoclonal antibody anti rhd
12/07/2011	CN102272130A [4-(6-氟-7-甲基氨基-2,4-二氧代-1,4-二氢-2h-喹唑啉-3-基)-苯基]-5-氯-噻吩-2-基-磺酰基脲盐、其相关的形式和方法 [4- (6-fluoro-7-methyl-amino-2,4-dioxo-1,4-dihydro--2h- quinazolin-3-yl) - phenyl] -5-chloro - thiophene - 2- group - sulfonylurea salt, and its related forms and methods
12/07/2011	CN102272119A 作为沉默调节蛋白调节剂的吡啶、双环吡啶和相关的类似物 As a sirtuin modulator of pyridine, pyridine and related bicyclic analogs
12/07/2011	CN102271663A 控制释放在低pH下水溶性差的可电离活性药物的固体组合物及其用法 Controlled release at low pH, the activity of a poorly water soluble ionizable solid pharmaceutical compositions and their use
12/07/2011	CN102268353A 一种枸杞酒及其制作方法 One kind of wolfberry wine and its production method
12/07/2011	CN102268098A 墨旱莲多糖铁络合物制备方法及其应用 Eclipta polysaccharide iron complex preparation method and its application
12/07/2011	CN102268083A 脱端基纤维蛋白原及其制备方法和应用 Off the end groups of fibrinogen and its preparation method and application
12/07/2011	CN102268013A 噻二唑衍生物、其制备方法和用途 Thiadiazole derivatives, their preparation and use
12/07/2011	CN102268012A 噻唑衍生物、其制备方法和用途 Thiazole derivatives, their preparation and use
12/07/2011	CN102267977A 一种3-取代苯并[c]呋喃酮的硫代、硒代同系物、其制备方法及医药用途 One 3-substituted benzo [c] furan ketone thio, seleno homologues, their preparation and pharmaceutical use
12/07/2011	CN102266549A 一种含有阿加曲班的注射用制剂 Containing argatroban injectable formulation
12/07/2011	CN102266484A 一种防治心脑血管疾病的葛根酒及制备方法和应用 For preventing and treating cardiovascular and cerebrovascular diseases, Pueraria wine and preparation method and application
12/07/2011	CN102266472A 预防和/或治疗糖尿病肾病的中药组合物及其制备方法 Prevention and / or treatment of diabetic nephropathy in Chinese medicine composition and its preparation method
12/07/2011	CN102266437A 紫珠叶真空冷冻干燥工艺、紫珠叶粉的制备工艺 Callicarpa leaf vacuum freeze-drying process, the preparation process Callicarpa leaf powder
12/07/2011	CN102266390A 楮叶黄酮的提取方法 Mulberry leaf flavonoids extraction method
12/07/2011	CN102266374A 臭参有效成分的提取方法 Participation smelly active ingredient extraction method
12/07/2011	CN102266362A 从棉籽壳中提取精制棉籽黄酮的方法 Extracted from cottonseed hulls in refined cottonseed flavonoids
12/07/2011	CN102266353A 阿胶泡腾颗粒剂及其制备方法 Gelatin granules in its preparation method
12/07/2011	CN102266352A 一种阿胶泡腾颗粒剂及其制备方法 One kind of gelatin granules in its preparation method
12/07/2011	CN102266315A 抗血小板聚集的药物 Anti-platelet aggregation drugs
12/07/2011	CN102266313A 建立斑马鱼血栓模型的方法及筛选抗栓/致栓药物的方法 Methods zebrafish model of thrombosis and screening antithrombotic / drug-induced bolt method
12/07/2011	CN102008658B 一种用于治疗脑血栓的中药胶囊 Medicine capsule for the treatment of cerebral thrombosis
12/07/2011	CN101912466B 治疗湿疹、皮炎、止痒、止血中成药 Treatment of eczema, dermatitis, itching, bleeding medicine
12/07/2011	CN101912437B Chinese medicinal composition for improving bone marrow depression caused by radiotherapy and chemotherapy and preparation method thereof
12/07/2011	CN101812025B 吡嗪芳酸醚类化合物、制备方法和医药应用 Pyrazine aromatic acid ether compounds, preparation method and medical applications
12/07/2011	CN101785810B 一种治疗过敏性紫癜的中药制剂 A treatment for allergic purpura Chinese medicine
12/07/2011	CN101732534B 一种补肾生精益气养血的中药及该中药丸剂的制备方法 Method for preparing Bushenshengjing BNI medicine and the medicine pills
12/07/2011	CN101698070B 治疗贫血引起的面色苍白、头晕、眼前发黑的中药 Treatment of anemia caused by pale complexion, dizziness, blackouts medicine
12/07/2011	CN101594863B 具有改进稳定性的涂膜制剂 Coating formulations with improved stability
12/07/2011	CN101554399B 一种具有免疫增强作用的补骨脂提取物及应用 Psoralen extract and apply an immune enhancing effect
12/07/2011	CN101318993B 以3S-四氢-β-咔啉-3-羧酸为连接臂的杂交肽、其制备方法及应用 In 3S- tetrahydro -β- carboline-3-carboxylic acid hybridization for the connecting arm peptides, their preparation and use
12/07/2011	CN101278970B 东紫苏类黄酮的制备方法 Preparation East basil flavonoids
12/07/2011	CN101199586B 一种用于紫癜的药物 A medicament for purpura
12/07/2011	CN101134049B 一种增强免疫力和/或改善贫血的阿胶粉的制备方法 An immunity and preparation / or improve anemia A powder enhancements
12/07/2011	CN101054344B 脂氧素A<sub>4</sub>类似物 Lipoxin A <sub> 4 </ sub> analogue
12/07/2011	CA2742032A1 Compositions and methods for treating myelodysplastic syndrome
12/07/2011	CA2742030A1 Compositions and methods for treating myelodysplastic syndrome
12/06/2011	US8071654 Inhibitors of thromboxane formation and action
12/06/2011	US8071539 Albumin fusion proteins
12/06/2011	CA2537054C 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester-methanesulphonate and use thereof as a medicament
12/06/2011	CA2485351C Cyanoguanidine prodrugs
12/06/2011	CA2460489C Pegylated and diglycosylated erythropoietin
12/01/2011	WO2011150393A2 Methods for improving maternal and fetal health
12/01/2011	WO2011150299A2 Treatment of myocardial infarction and vascular injury with netrin-1
12/01/2011	WO2011149841A1 SUBSTITUTED THIAZOLIDINEDIONE INDAZOLES, INDOLES AND BENZOTRIAZOLES AS ESTROGEN-RELATED RECEPTOR-α MODULATORS
12/01/2011	WO2011149016A1 Complex containing thrombolytic enzyme
12/01/2011	WO2011149011A1 Novel indazole derivative or salt thereof, manufacturing intermediate therefor, antioxidant using same, and use for an indazole derivative or salt thereof
12/01/2011	WO2011147086A1 Microvesicles carrying small interfering rnas, preparation methods and uses thereof
12/01/2011	WO2011090306A3 Liquid formulations for long-acting erythropoietin conjugate
12/01/2011	US20110295225 Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof
12/01/2011	US20110294892 Use of histone deacetylase inhibitors for the care of Philadephia-negative myeloproliferative syndromes
12/01/2011	US20110294878 Inhibitors of Dimethylarginine Dimethylaminohydrolase
12/01/2011	US20110294870 Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
12/01/2011	US20110294868 Modulation of transthyretin expression
12/01/2011	US20110294864 Aqueous coacervate compositions suitable for making powders and water-soluble formulations of biologically-active agents
12/01/2011	US20110294841 Novel statin pharmaceutical compositions and related methods of treatment
12/01/2011	US20110294816 Pyrrolotriazine kinase inhibitors
12/01/2011	US20110294815 Prostacyclin analogs
12/01/2011	US20110294796 Benzotriazine inhibitors of kinases

1 ... 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 ... 671